Clinical Trials Browser

Phase 2 × Neoplasms × liposomal doxorubicin × Clear all

NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Phase 2 Active not recruiting

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT03164993 2024-10-15

ALICE

Phase 2 Completed

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

NCT03409198 2024-10-15

ICON

Phase 2 Completed

Breast Neoplasms, Neoplasms

NCT00913835 2019-09-26

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

Phase 2 Completed

125 enrolled 20 charts

Neoplasms, Ovarian Neoplasms

NCT00563953 2017-10-12

CAPRICE

Phase 2 Completed

Breast Neoplasms, Heart Diseases, Neoplasms

NCT00523380 2017-03-01

Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer

Phase 2 Completed

Neoplasms, Ovarian Neoplasms

NCT00758732 2015-09-28

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

NCT00722592 2015-01-07

PRECEDENT

Phase 2 Completed

Neoplasms, Ovarian Neoplasms